News
- Author:
- Sue Hughes
Publish date: December 16, 2022
The Diuretic Comparison Project trial, showing no difference in clinical events between diuretics chlorthalidone and hydrochlorothiazide for hypert...
News
- Author:
- Sue Hughes
Publish date: December 12, 2022
A large new case-control study has shown a reduced risk of both lobar and nonlobar intracerebral hemorrhage with statin use, providing reassurance ...
News
- Author:
- Sue Hughes
Publish date: December 7, 2022
“Identifying the optimal mixture of micronutrients is important, as not all are beneficial.”
News
- Author:
- Sue Hughes
Publish date: November 30, 2022
Higher levels of lipoprotein(a) are associated with risk similar to that seen with familial hypercholesterolemia, but with risk starting as low as ...
News
- Author:
- Sue Hughes
Publish date: November 11, 2022
PREVENT-HD joins a long list of smaller trials also showing no benefit of anticoagulation in nonhospitalized COVID-19 patients.
News
- Author:
- Sue Hughes
Publish date: November 9, 2022
The combination product containing quarter doses of four different drugs reduced blood pressure by almost 5 mm Hg more than a standard dose of one ...
News
- Author:
- Sue Hughes
Publish date: November 7, 2022
The open-label trial could add some support to findings from the REDUCE-IT study, which showed a reduction in cardiovascular events with high-dose ...
News
- Author:
- Sue Hughes
Publish date: November 5, 2022
Cardiovascular events were nearly identical with two different hypertension drugs in the randomized Diuretic Comparison Project trial.
News
- Author:
- Sue Hughes
Publish date: November 3, 2022
Although there were promising signs of a potential reduced bleeding risk in intracranial hemorrhage, the DUMAS study showed no benefit on the prima...
News
- Author:
- Sue Hughes
Publish date: October 31, 2022
“This result is not what we expected, but it is a definitive result and gives us a lower safety margin for blood pressure in acute ischemic stroke ...
News
- Author:
- Sue Hughes
Publish date: October 31, 2022
The MR CLEAN-LATE trial shows patients selected for thrombectomy on the presence of collateral flow had a greater chance of a better functional out...
News
- Author:
- Sue Hughes
Publish date: October 3, 2022
The antiplatelet strategy after PCI is currently shifting to reduce the duration of DAPT.
News
- Author:
- Sue Hughes
Publish date: September 30, 2022
A new analysis of the ASPREE primary prevention trial of aspirin has shown a net clinical benefit in those with genotypes associated with raised le...
News
- Author:
- Sue Hughes
Publish date: September 15, 2022
Cumulative systolic BP load, calculating the magnitude and duration of hypertension from serial measures, may provide better prediction of major CV...
News
- Author:
- Sue Hughes
Publish date: September 9, 2022
More details of the positive results with the RNAi therapeutic on functional capacity and quality of life were reported.
